Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00

ClinicalTrials.gov ID: NCT03280108

Public ClinicalTrials.gov record NCT03280108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03280108
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Alcon Research
Industry
Enrollment
250 participants

Conditions and interventions

Conditions

Interventions

  • AcrySof IQ PanOptix Multifocal IOL Device
  • AcrySof Monofocal IOL Device

Device

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2017
Primary completion
Sep 26, 2018
Completion
Sep 26, 2018
Last update posted
Oct 9, 2019

2017 – 2018

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Alcon Investigative Site Fresno California 93720
Alcon Investigative Site Mt. Dora Florida 32757
Alcon Investigative Site Panama City Florida 32405
Alcon Investigative Site Poughkeepsie New York 12603
Alcon Investigative Site Mt. Pleasant South Carolina 29464
Alcon Investigative Site Sioux Falls South Dakota 57108
Alcon Investigative Site Nashville Tennessee 37205
Alcon Investigative Site Houston Texas 77027
Alcon Investigative Site Hurst Texas 76054
Alcon Investigative Site Nacogdoches Texas 75965
Alcon Investigative Site Salt Lake City Utah 84107
Alcon Investigative Site Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03280108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03280108 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →